NEURIM PHARMACEUTICALS RECEIVES EUROPEAN MARKETING AUTHORIZATION FOR PEDIATRIC PROLONGED-RELEASE MELATONIN (SLENYTO®) FOR THE TREATMENT OF INSOMNIA IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)

TEL AVIV, Israel, March 26, 2025 /PRNewswire/ — Neurim Pharmaceuticals ("Neurim") announces…

Bairong Inc. Announces 2024 Annual Financial Results

Solid Revenue Growth Coupled with High Gross Profit Margin (73%) and Non-IFRS…

IMAGO Technologies Wins German Design Award 2025 & Launches FREE AI Online Whiteboard Trial

NEW YORK, March 26, 2025 /PRNewswire/ — IMAGO Technologies, a leader in…

Zhihu Inc. Reports Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results

BEIJING, March 26, 2025 /PRNewswire/ — Zhihu Inc. ("Zhihu" or the "Company")…

Cheetah Mobile Announces Fourth Quarter and Fiscal Year 2024 Unaudited Consolidated Financial Results

BEIJING, March 26, 2025 /PRNewswire/ — Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile"…

Antengene to Present Results From Four Cutting Edge Preclinical Studies at AACR 2025 with Focuses Including AnTenGagerTM TCEs and Synthetic Lethality

SHANGHAI and HONG KONG, March 26, 2025 /PRNewswire/ — Antengene Corporation Limited ("Antengene",…

Fangzhou Inc. Partners with Tencent Health and Tencent Cloud to Accelerate Development of AI-Enabled Healthcare Services

SHANGHAI, March 26, 2025 /PRNewswire/ — Fangzhou Inc. ("Fangzhou" or the "Company")…

GoodWe Powers Wildlife Rescue with Donated Solar System in Australia

ADELAIDE, Australia, March 26, 2025 /PRNewswire/ — GoodWe’s commitment to sustainability continues…